Omnigel strengthens its portfolio with the introduction of Omnigel Maxstrong

The new variant is built for individuals whose active routines often lead to repeated muscle and joint discomfort Marks its entry into the 2% diclofenac category to address recurring pain with long-lasting relief MUMBAI, India, July 6, 2026 /PRNewswire/ — Omnigel, Cipla Health’s leading pain relief brand, has announced the launch of Omnigel Maxstrong, its [...]